Previously, we performed genomic sequencing of 207 Japanese GCs using a 435-gene panel and identified BRCA1/2 mutations in tumor.17 In this study, we conducted BRCA1/2 genetic testing in seven Japanese patients with GC whose tumor had BRCA1/2 mutations. The gene discussed is BRCA1; the disease is neoplasm.